GPRC5A and lung carcinoma: According to recent reports, the expression of GPRC5A is the highest in disease-free normal bronchial epithelia (NBE), intermediate in cancer-free lungs from patients with chronic obstructive pulmonary disease (COPD) and the lowest in patients with COPD and lung cancer [77].